Intelligence / Epithalon

Epithalon

Available
Telomerase Activator
Schedule
Unscheduled
Available
Enforcement
Monitoring
Medium Risk
Providers
2
Access: Open
Key Facts
Currently Unscheduled
Synthetic tetrapeptide
2 identified Australian providers
Regulatory status may change
Less regulated than S4 peptides

Overview

Epithalon (Epitalon) is a synthetic tetrapeptide based on the natural peptide epithalamin produced by the pineal gland. It is currently unscheduled by the TGA, making it one of the few peptides available without a prescription in Australia. However, its regulatory status could change.

Australian Scheduling

Currently Unscheduled - not classified under the Poisons Standard. This means it is not currently a prescription-only medicine. However, the TGA is monitoring its use and classification could change.

Access Pathway

Available through some clinics and may be sourced without a prescription. 2 identified providers offering it through clinical channels. The unscheduled status makes this peptide uniquely accessible but also less regulated.

Regulatory Notice

For informational purposes only. TGA scheduling may change without notice. All Schedule 4 peptides require a valid prescription from a registered Australian medical practitioner. This site does not sell, supply, or facilitate access to therapeutic goods. Data compiled from TGA SUSMP, public provider directories, and publicly available review platforms.

Are You a Practitioner?

List your clinic for free and reach patients actively searching for legal peptide access in Australia.